Arcadia Historical Financial Ratios
| RKDA Stock | USD 3.91 0.05 1.30% |
Arcadia Biosciences is presently reporting on over 109 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 8.78, Invested Capital of 0.0, Average Payables of 0.0 or Stock Based Compensation To Revenue of 0.12 will help investors to properly organize and evaluate Arcadia Biosciences financial condition quickly.
Arcadia |
About Arcadia Financial Ratios Analysis
Arcadia BiosciencesFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Arcadia Biosciences investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Arcadia financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Arcadia Biosciences history.
Arcadia Biosciences Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Arcadia Biosciences stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Arcadia Biosciences sales, a figure that is much harder to manipulate than other Arcadia Biosciences multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Arcadia Biosciences dividend as a percentage of Arcadia Biosciences stock price. Arcadia Biosciences dividend yield is a measure of Arcadia Biosciences stock productivity, which can be interpreted as interest rate earned on an Arcadia Biosciences investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Inventory Turnover
A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.Most ratios from Arcadia Biosciences' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Arcadia Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Arcadia Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For information on how to trade Arcadia Stock refer to our How to Trade Arcadia Stock guide.At present, Arcadia Biosciences' PTB Ratio is projected to increase significantly based on the last few years of reporting. The current year's Days Sales Outstanding is expected to grow to 79.74, whereas Price To Sales Ratio is forecasted to decline to 0.79.
| 2024 | 2025 (projected) | |
| Dividend Yield | 0.002042 | 0.001815 |
| Price To Sales Ratio | 0.84 | 0.79 |
Arcadia Biosciences fundamentals Correlations
Click cells to compare fundamentals
Arcadia Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Arcadia Biosciences fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Price To Sales Ratio | 3.14 | 3.26 | 0.65 | 0.73 | 0.84 | 0.79 | |
| Ptb Ratio | 0.91 | 0.71 | 0.31 | 0.3 | 0.27 | 0.28 | |
| Days Sales Outstanding | 63.88 | 73.75 | 44.76 | 35.2 | 40.48 | 79.74 | |
| Book Value Per Share | 114.68 | 58.64 | 34.87 | 10.27 | 9.24 | 8.78 | |
| Free Cash Flow Yield | (1.29) | (1.21) | (2.16) | (3.95) | (4.54) | (4.32) | |
| Operating Cash Flow Per Share | (121.37) | (48.62) | (23.32) | (12.36) | (11.13) | (11.68) | |
| Stock Based Compensation To Revenue | 1.96 | 0.25 | 0.23 | 0.11 | 0.13 | 0.12 | |
| Capex To Depreciation | 3.53 | 0.96 | 0.15 | 0.005081 | 0.004573 | 0.004345 | |
| Pb Ratio | 0.91 | 0.71 | 0.31 | 0.3 | 0.27 | 0.28 | |
| Ev To Sales | 2.55 | (0.48) | (1.22) | (0.31) | (0.35) | (0.34) | |
| Free Cash Flow Per Share | (130.75) | (50.52) | (23.44) | (12.37) | (11.13) | (11.69) | |
| Roic | (0.73) | (0.49) | (0.87) | (0.82) | (0.74) | (0.78) | |
| Inventory Turnover | 1.36 | 1.96 | 3.81 | 1.69 | 1.94 | 2.56 | |
| Net Income Per Share | (24.2) | (30.33) | (26.05) | (11.3) | (10.17) | (10.68) | |
| Days Of Inventory On Hand | 267.62 | 185.81 | 95.74 | 216.57 | 194.91 | 187.08 | |
| Payables Turnover | 7.16 | 6.17 | 10.83 | 4.12 | 3.71 | 3.82 | |
| Research And Ddevelopement To Revenue | 0.99 | 0.57 | 0.15 | 0.26 | 0.3 | 0.28 | |
| Capex To Revenue | 0.29 | 0.15 | 0.007232 | 9.38E-4 | 8.44E-4 | 8.02E-4 | |
| Cash Per Share | 103.09 | 53.92 | 34.44 | 9.41 | 10.82 | 10.28 | |
| Pocfratio | (0.83) | (0.86) | (0.46) | (0.25) | (0.23) | (0.24) | |
| Capex To Operating Cash Flow | (0.0773) | (0.0389) | (0.005151) | (3.27E-4) | (3.76E-4) | (3.95E-4) | |
| Pfcf Ratio | (0.77) | (0.82) | (0.46) | (0.25) | (0.23) | (0.24) | |
| Days Payables Outstanding | 50.97 | 59.14 | 33.7 | 88.6 | 101.88 | 141.88 | |
| Income Quality | 0.6 | 5.01 | 1.6 | 0.9 | 1.09 | 0.98 | |
| Roe | (0.22) | (0.52) | (0.74) | (1.09) | (1.25) | (1.19) | |
| Ev To Operating Cash Flow | (0.68) | 0.13 | 0.87 | 0.11 | 0.0965 | 0.1 | |
| Pe Ratio | (4.18) | (1.37) | (0.42) | (0.28) | (0.25) | (0.26) | |
| Return On Tangible Assets | (0.13) | (0.37) | (0.54) | (0.71) | (0.64) | (0.67) | |
| Ev To Free Cash Flow | (0.63) | 0.12 | 0.86 | 0.11 | 0.0964 | 0.1 | |
| Earnings Yield | (0.24) | (0.73) | (2.4) | (3.61) | (4.15) | (3.95) | |
| Net Debt To E B I T D A | 0.86 | 1.09 | 1.36 | 0.41 | 0.37 | 0.19 | |
| Current Ratio | 4.98 | 5.02 | 7.02 | 6.03 | 4.17 | 3.75 | |
| Tangible Book Value Per Share | 111.55 | 57.73 | 34.8 | 10.24 | 9.21 | 8.75 | |
| Receivables Turnover | 5.71 | 4.95 | 8.15 | 10.37 | 9.33 | 4.86 | |
| Graham Number | 246.26 | 199.7 | 143.4 | 51.38 | 59.09 | 56.14 | |
| Shareholders Equity Per Share | 111.36 | 58.44 | 35.09 | 10.38 | 9.34 | 8.88 | |
| Debt To Equity | 0.34 | 0.11 | 0.0959 | 0.0784 | 0.0706 | 0.0741 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Arcadia Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Arcadia Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Arcadia Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Arcadia Biosciences Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Arcadia Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For information on how to trade Arcadia Stock refer to our How to Trade Arcadia Stock guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Agricultural Products & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arcadia Biosciences. If investors know Arcadia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arcadia Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.285 | Earnings Share (6.77) | Revenue Per Share | Quarterly Revenue Growth 0.184 | Return On Assets |
The market value of Arcadia Biosciences is measured differently than its book value, which is the value of Arcadia that is recorded on the company's balance sheet. Investors also form their own opinion of Arcadia Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Arcadia Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arcadia Biosciences' market value can be influenced by many factors that don't directly affect Arcadia Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arcadia Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arcadia Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arcadia Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.